Molecular and biologic determinants of neoadjuvant chemotherapy of locoregional breast cancer.
Bhalla
K
K
Department of Medicine, Winship Cancer Center, Emory University School of Medicine, Atlanta, GA 30322, USA.
Harris
W B
WB
D000970:Antineoplastic Agents / Q000627:therapeutic use; D017209:Apoptosis; D015415:Biomarkers; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology*; D002453:Cell Cycle; D002470:Cell Survival; D017024:Chemotherapy, Adjuvant; D000077143:Docetaxel; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D017239:Paclitaxel / Q000031:analogs & derivatives / Q000627:therapeutic use; D010641:Phenotype; D043823:Taxoids
D000970:Antineoplastic Agents; D015415:Biomarkers; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel